Group 1 - The core viewpoint of the report is that the company, Prosperity Industrial Trust (00778), is expected to announce its full-year results for 2025 in early March 2026, with a maintained buy rating and a target price of HKD 5.92 [1] - The overall occupancy rate of Prosperity is anticipated to see a slight improvement in the second half of 2025, aided by recent asset enhancement projects and the introduction of new dining options and fitness centers [2] - The retail sales market is showing signs of recovery, primarily driven by an increase in tourists, which is benefiting sales in core areas and non-essential goods [2] Group 2 - The company has slightly adjusted its revenue and distribution forecasts for 2025-2027 due to the ongoing stabilization of the Hong Kong retail market, but expects improvements in stock and real estate performance to contribute to wealth effects in the medium to long term [3] - The target price remains unchanged, and the company’s retail portfolio, focused on essential consumption, is expected to maintain resilience and high occupancy rates [4] - The potential inclusion in the Stock Connect program is viewed as a key catalyst for the next 12 months, with the impact of interest rate cuts expected to outweigh the effects of rental adjustments [4]

Group 1 - The core message of the event is to attract talent and investment from Hong Kong to Changsha, emphasizing the city's commitment to supporting various types of talent through comprehensive policies and initiatives [1][2] - The "Changsha Talent Policy Map" outlines support pathways for different talent categories, including top scientists and young entrepreneurs, highlighting financial empowerment and quality of life services [1][2] - Changsha has established itself as a significant economic partner for Hong Kong, with 679 Hong Kong-funded enterprises accounting for 46.6% of the city's total foreign investment [2] Group 2 - The event facilitated collaborations between Changsha and Hong Kong, including the signing of research project agreements and the establishment of a "Changsha Enterprises Listing Hong Kong Home" initiative [2] - The orange map serves as a tangible symbol of the connection between the two cities, representing an invitation for talent and opportunities beyond mere policy documentation [2][3] - The ongoing collaboration between Changsha and Hong Kong is expected to continue evolving, promising further developments in talent cultivation and technological innovation [3]

据港媒消息，市场传闻以保密形式申请赴香港IPO的爱芯元智，最快将于本月招股。 消息指，爱芯元智拟募资约4亿美元， 中金公司、国泰君安和 交银国际负责是次IPO事宜。 爱芯元智，成立于2019年，专注于边缘侧和端侧AI芯片的研发。 爱芯元智，历经数轮融资，其投资者可能包括韦豪创芯、启明创投、沄柏资本、 美团、元禾璞华、 腾讯投资 、宁波通商基金、镇海产 投、重庆产业投资母基金、重庆两江基金、联想之星、和聚资本、纪源资本、耀途资本、旺泰恒辉投资基金、华晏资本、石溪资本、酷 讯旅游、成从武、博裕资本、冯源资本、万物资本、佑柏资产、天创资本等。 ...

爱芯元智历经数轮融资，投资者可能包括韦豪创芯、启明创投、沄柏资本、美团、元禾璞华、腾讯投 资、宁波通商基金、镇海产投、重庆产业投资母基金、重庆两江基金等。 智通财经APP获悉，据媒体消息，市场传闻以保密形式申请赴香港IPO的爱芯元智，最快将于本月招 股。消息指，爱芯元智拟募资约4亿美元，中金公司、国泰君安和交银国际负责本次IPO事宜。 据悉，爱芯元智是一家人工智能感知与边缘计算芯片研发商，服务终端计算、智能驾驶、边缘计算等市 场。集强大算力与超低功耗于一体，采用算法和芯片的协同设计理念，爱芯元智自研两大核心技术—— 爱芯智眸AI-ISP和爱芯通元混合精度NPU。 ...

Group 1 - The core viewpoint of the article highlights that Rongchang Biologics (09995) has seen a stock increase of over 5%, currently trading at 98.1 HKD with a transaction volume of 137 million HKD [1] - The report from CMB International indicates that Rongchang Biologics has entered into an exclusive licensing agreement with AbbVie for RC148, granting AbbVie exclusive rights for development, production, and commercialization outside Greater China [1] - Rongchang Biologics will receive an upfront payment of 650 million USD, with potential milestone payments of up to 4.95 billion USD, along with a double-digit percentage tiered sales royalty [1] Group 2 - CMB International believes that the transaction will have limited short-term direct impact on competing products due to the first-mover advantage of companies like Kangfang Biologics and 3SBio in clinical progress [1] - The firm is optimistic about the overseas registration research progress of Taitasip and Vidisirimab by 2026, as well as the advancement of early-stage products in more indications [1] - CMB International has raised its revenue forecast for Rongchang Biologics for 2026 to 2027 and increased the target price to 136 HKD [1]

Core Viewpoint - The announcement indicates that China International Capital Corporation (CICC) will acquire CSI notes worth $10 million at a purchase price of $100 per note on January 13, 2026, through the over-the-counter market [1] Group 1 - CICC is set to purchase CSI notes amounting to $10 million [1] - The acquisition price is established at $100 per note [1] - The transaction will take place in the over-the-counter market [1]

Core Viewpoint - The company,交银国际, announced the acquisition of CSI notes worth $10 million at a purchase price of $100 per note, scheduled for January 13, 2026 [1] Group 1 - The acquisition involves a total amount of $10 million in CSI notes [1] - The purchase price for each note is set at $100 [1] - The transaction will take place in the over-the-counter market [1]

格隆汇1月14日丨交银国际(03329.HK)公告，于2026年1月13日，公司的直接全资附属公司Preferred Investment于场外市场以购买价100美元收购本金额为1000万美元的CSI票据，代价约为1000万美元(相当 于约7850万港元). ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 BOCOM INTERNATIONAL HOLDINGS COMPANY LIMITED 交銀國際控股有限公司 （於香港註冊成立的有限公司） （股份代號：3329） 有關收購票據之 須予披露交易 收購 於2026年1月13日，Preferred Investment於場外市場以購買價100美元收購本金額為 10,000,000美元的CSI票據，代價約為10,000,000美元（相當於約78,500,000港元）。 上市規則之涵義 由於有關收購的一項或多項適用百分比率低於25%但高於5%，收購構成本公司一項須 予披露交易，因此須遵守上市規則第14章項下的通告及公告規定。 收購 於2026年1月13日，Preferred Investment於場外市場以購買價100美元收購本金額為 10,000,000美元的CSI票據，代價約為10,000,000美元（相當於約78,500,000港元）。本集 團將動用內部 ...

Core Viewpoint - The article discusses the rising trend of knowledge monetization in the financial industry, highlighting how financial professionals are leveraging their expertise to create subscription-based services and courses, thus generating significant revenue despite the challenges in traditional investment avenues [6][20]. Group 1: Knowledge Monetization Trends - Financial figures indicate that 洪灏's knowledge platform saw a GMV of 12.586 million yuan within two months of a price increase to 1499 yuan per year, up from 899 yuan [6]. - 李蓓's course, priced at 12,888 yuan, sold out in two days, generating 2.57 million yuan in revenue [6]. - The article notes that the media sector is generally considered a poor business, yet knowledge monetization through private domains and courses stands out as a lucrative opportunity [6]. Group 2: Leveraging Different Types of Leverage - 纳瓦尔 identifies three types of leverage for wealth creation: labor leverage, capital leverage, and the most crucial, the ability to replicate products with zero marginal cost, such as code and media [8]. - 洪灏 and 李蓓 effectively utilize all three types of leverage, with 李蓓's company 半夏 surpassing 10 billion yuan in scale by 2022 [8][12]. - The article emphasizes that the ability to create engaging content and attract a large audience is essential for maximizing the benefits of these leverages [12]. Group 3: Performance and Market Positioning - 洪灏's investment performance has been inconsistent, with a notable spike in August 2023 when a fund he managed saw an 8.98% increase, but prior performance was lackluster [10]. - Despite questions about his actual investment results, 洪灏's marketing skills and ability to create compelling narratives have helped him attract a significant following [12][15]. - The article contrasts 洪灏's approach with 李蓓's, noting that while 洪灏 focuses on macroeconomic predictions, 李蓓 has adopted strategies to retain clients through free courses and engagement [18][19]. Group 4: Market Dynamics and Client Engagement - The financial industry is experiencing pressure from salary reductions, prompting professionals to seek alternative income sources through knowledge monetization [20]. - Investors are increasingly looking for reliable information sources, creating a demand for knowledgeable fund managers who can provide insights and emotional reassurance in a chaotic market [20]. - The article suggests that successful fund managers are adapting by targeting high-value clients and leveraging their expertise to create tailored educational content [21].